346 related articles for article (PubMed ID: 35285869)
1. Evaluating Rates of Recurrent Ischemic Stroke Among Young Adults With Embolic Stroke of Undetermined Source: The Young ESUS Longitudinal Cohort Study.
Perera KS; de Sa Boasquevisque D; Rao-Melacini P; Taylor A; Cheng A; Hankey GJ; Lee S; Fabregas JM; Ameriso SF; Field TS; Arauz A; Coutts SB; Arnold M; Mikulik R; Toni D; Mandzia J; Veltkamp RC; Meseguer E; Haeusler KG; Hart RG;
JAMA Neurol; 2022 May; 79(5):450-458. PubMed ID: 35285869
[TBL] [Abstract][Full Text] [Related]
2. Chronic ischemic lesions and presence of patent foramen ovale in young adults with embolic stroke of undetermined source: Results of the young ESUS patient registry.
Meinel TR; Tsiplova K; Taylor A; Meseguer E; Haeusler KG; Hart RG; Arnold M; Perera KS
Int J Stroke; 2024 Apr; 19(4):470-477. PubMed ID: 37981572
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial.
Veltkamp R; Pearce LA; Korompoki E; Sharma M; Kasner SE; Toni D; Ameriso SF; Mundl H; Tatlisumak T; Hankey GJ; Lindgren A; Berkowitz SD; Arauz A; Ozturk S; Muir KW; Chamorro Á; Perera K; Shuaib A; Rudilosso S; Shoamanesh A; Connolly SJ; Hart RG
JAMA Neurol; 2020 Oct; 77(10):1233-1240. PubMed ID: 32628266
[TBL] [Abstract][Full Text] [Related]
4. Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS.
Diener HC; Chutinet A; Easton JD; Granger CB; Kleine E; Marquardt L; Meyerhoff J; Zini A; Sacco RL
Stroke; 2021 Mar; 52(3):1065-1068. PubMed ID: 33504190
[TBL] [Abstract][Full Text] [Related]
5. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.
Kasner SE; Swaminathan B; Lavados P; Sharma M; Muir K; Veltkamp R; Ameriso SF; Endres M; Lutsep H; Messé SR; Spence JD; Nedeltechev K; Perera K; Santo G; Olavarria V; Lindgren A; Bangdiwala S; Shoamanesh A; Berkowitz SD; Mundl H; Connolly SJ; Hart RG;
Lancet Neurol; 2018 Dec; 17(12):1053-1060. PubMed ID: 30274772
[TBL] [Abstract][Full Text] [Related]
6. Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial.
Shoamanesh A; Hart RG; Connolly SJ; Kasner SE; Smith EE; Martí-Fàbregas J; Liu YY; Uchiyama S; Mikulik R; Veltkamp R; O'Donnell MJ; Ntaios G; Muir KW; Field TS; Santo GC; Olavarria V; Mundl H; Lutsep H; Berkowitz SD; Sharma M
JAMA Neurol; 2021 Jan; 78(1):11-20. PubMed ID: 33074284
[TBL] [Abstract][Full Text] [Related]
7. Ipsilateral Carotid Plaque Presence is Inversely Associated with Patent Foramen Ovale in Cryptogenic Stroke: A Multicenter CohortStudy.
Sathya A; Nguyen TN; Reyes-Esteves S; Kamen S; Hester T; Vigilante N; Woo J; Zhang L; Abdalkader M; Cucchiara B; Siegler JE
J Stroke Cerebrovasc Dis; 2022 Aug; 31(8):106606. PubMed ID: 35749935
[TBL] [Abstract][Full Text] [Related]
8. From cryptogenic to ESUS: Toward precision medicine?
Timsit S
Rev Neurol (Paris); 2022 Nov; 178(9):939-952. PubMed ID: 35597610
[TBL] [Abstract][Full Text] [Related]
9. Long-term (>10-year) clinical follow-up after young embolic stroke/TIA of undetermined source.
Nassif M; Annink ME; Yang H; Rettig T; Roos Y; van den Brink R; Tijssen J; Mulder B; de Winter RJ; Bouma BJ
Int J Stroke; 2021 Jan; 16(1):7-11. PubMed ID: 31679479
[TBL] [Abstract][Full Text] [Related]
10. Age-related burden and characteristics of embolic stroke of undetermined source in the real world clinical practice.
Grifoni E; Giglio D; Guazzini G; Cosentino E; Latini E; Dei A; Del Rosso A; Guarnaccia V; Baldini M; Bartolozzi ML; Martinucci P; Sani F; Giordano A; Dainelli F; Maggi F; Giulietti C; Romagnoli M; Cinotti S; Schipani E; Murgida GS; Di Martino S; Cozzi A; Carli Ballola A; Dacomo D; Valori D; Masotti L
J Thromb Thrombolysis; 2020 Jan; 49(1):75-85. PubMed ID: 31494844
[TBL] [Abstract][Full Text] [Related]
11. Localization of Infratentorial Lesion could Predict Patent Foramen Ovale as an Etiology in Embolic Stroke of Undetermined Source.
Ishizuka K; Toi S; Hoshino T; Higuchi E; Kitagawa K
J Atheroscler Thromb; 2022 May; 29(5):785-793. PubMed ID: 33952811
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of Cryptogenic Stroke With Patent Foramen Ovale at Older Ages and Implications for Trials: A Population-Based Study and Systematic Review.
Mazzucco S; Li L; Rothwell PM
JAMA Neurol; 2020 Oct; 77(10):1279-1287. PubMed ID: 32628255
[TBL] [Abstract][Full Text] [Related]
13. Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin: A Subgroup Analysis of the NAVIGATE ESUS Randomized Clinical Trial.
Merkler AE; Pearce LA; Kasner SE; Shoamanesh A; Birnbaum LA; Kamel H; Sheth KN; Sharma R
JAMA Neurol; 2021 Dec; 78(12):1454-1460. PubMed ID: 34694346
[TBL] [Abstract][Full Text] [Related]
14. Embolic Stroke of Undetermined Source and Patent Foramen Ovale: Risk of Paradoxical Embolism Score Validation and Atrial Fibrillation Prediction.
Strambo D; Sirimarco G; Nannoni S; Perlepe K; Ntaios G; Vemmos K; Michel P
Stroke; 2021 May; 52(5):1643-1652. PubMed ID: 33784832
[TBL] [Abstract][Full Text] [Related]
15. Catch-up-ESUS - follow-up in embolic stroke of undetermined source (ESUS) in a prospective, open-label, observational study: study protocol and initial baseline data.
Feil K; Heinrich J; Küpper C; Müller K; Laub C; von Falkenhausen AS; Becker R; Wollenweber FA; Kääb S; Sinner MF; Kellert L
BMJ Open; 2019 Dec; 9(12):e031716. PubMed ID: 31822542
[TBL] [Abstract][Full Text] [Related]
16. Risk of recurrent ischemic stroke in young cryptogenic patients with embolic stroke of undetermined source.
Šaňák D; Divišová P; Hutyra M; Král M; Bártková A; Zapletalová J; Látal J; Dorňák T; Hudec Š; Franc D; Polidar P; Veverka T; Kaňovský P
J Neurol Sci; 2020 Sep; 416():116985. PubMed ID: 32563078
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial.
Hart RG; Veltkamp RC; Sheridan P; Sharma M; Kasner SE; Bangdiwala SI; Ntaios G; Shoamanesh A; Ameriso SF; Toni D; Czlonkowska A; Lindgren A; Hankey GJ; Perera KS; Shuaib A; Coutts SB; Gagliardi RJ; Berkowitz SD; Mundl H; Peters G; Connolly SJ;
J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2273-2279. PubMed ID: 31160218
[TBL] [Abstract][Full Text] [Related]
18. Embolic stroke of undetermined source: Focusing on atrial cardiopathy and patent foramen ovale.
Zhang M; Xiao Q; Wang K; Yin R; Liu G; Zhao H; Li P; Zhu X; Pan X
Int J Cardiol; 2024 May; 402():131810. PubMed ID: 38272131
[TBL] [Abstract][Full Text] [Related]
19. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
Bahit MC; Sacco RL; Easton JD; Meyerhoff J; Cronin L; Kleine E; Grauer C; Brueckmann M; Diener HC; Lopes RD; Brainin M; Lyrer P; Wachter R; Segura T; Granger CB;
Circulation; 2021 Nov; 144(22):1738-1746. PubMed ID: 34649459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
